← Back to headlines

Spain Launches First Human Trial for TET101 Gene Therapy Targeting Alzheimer’s
Neuroscientist Álvaro Pascual-Leone announces the inaugural human trials for TET101, a novel gene therapy designed to halt disease progression and restore lost cognitive functions in Alzheimer’s patients.
Sources
Showing 0 of 1 sources
No articles available in your preferred languages.
1 article available in other languages below.



